Published Online First: 2 June 2006. doi:10.1136/jcp.2006.037606
Journal of Clinical Pathology 2007;60:283-289
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Receptor-activated Smad localisation in Bleomycin-induced pulmonary fibrosis
Hiroyuki Higashiyama,
Daisuke Yoshimoto,
Yuji Okamoto,
Hideo Kikkawa,
Satoshi Asano,
Mine Kinoshita
Department of Pharmacology, Tsukuba Research Laboratories, GlaxoSmithKline, Tsukuba, Ibaraki, Japan
Correspondence to:
Dr S Asano
Department of Pharmacology, Tsukuba Research Laboratories, GlaxoSmithKline, 43 Wadai, Tsukuba, Ibaraki 300-4247, Japan;satoshi.asano{at}gsk.com
Background: Recent advances in fibrosis biology have identified transforming growth factor (TGF)-ß type I receptor-mediated activation of Smads as playing a central part in the development of fibrosis. However, to date, there have been few studies that examined the localisation and distribution of receptor-activated Smads protein (R-Smads: Smad2 and 3) during the fibrosis progression.
Aims: To histopathologically assess the time-course change of the localisation and distribution of the Smads protein in pulmonary fibrosis.
Methods: Pulmonary fibrosis was induced by intranasal injection of bleomycin (0.3 U/mouse). Lungs were isolated 2, 5, 7, 9 and 14 days after bleomycin treatment. Histological changes in the lungs were evaluated by haematoxylin-eosin stain or Massons trichrome stain, and scored. TGF-ß1, Smad3 and phosphorylated Smad2 localisations in lung tissues were determined by immunohistochemistry.
Results: The bleomycin treatment led to considerable pulmonary fibrotic changes accompanied by marked increase in TGF-ß1 expression in infiltrating macrophages. With the progression in fibrosis (day 714), marked increases in Smad3-positive and pSmad2-positive cells were observed. There were intense Smad3-positive and pSmad2-positive signals localised to the nuclei of the infiltrating macrophages and to type II epithelial cells, and less intense signals in fibroblasts and hyperplastic alveolar/bronchiolar epithelial cells.
Conclusions: The time-course data of TGF-ß1 and R-Smads indicate that progressive enhancement of TGF-ß1 signalling via R-Smad is activated in the process of fibrosis progression.
Abbreviations: ECM, extracellular matrix; TGF, transforming growth factor
This article has been cited by other articles:

|
 |

|
 |
 
J. X. Rong, Y. Qiu, M. K. Hansen, L. Zhu, V. Zhang, M. Xie, Y. Okamoto, M. D. Mattie, H. Higashiyama, S. Asano, et al.
Adipose Mitochondrial Biogenesis Is Suppressed in db/db and High-Fat Diet-Fed Mice and Improved by Rosiglitazone
Diabetes,
July 1, 2007;
56(7):
1751 - 1760.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.